Generated by AI
Shuttle Pharmaceuticals Holdings, Inc. is a clinical-stage pharmaceutical company focused on developing cancer therapies, with a particular emphasis on improving the effectiveness of radiation treatment. Its current work centers on radiation sensitizers and related oncology programs designed to support treatment outcomes across difficult-to-treat cancers. The company also owns an AI-driven molecular discovery platform, Molecule.ai, which is used for early-stage drug development and helps researchers explore and evaluate new chemical ideas more efficiently. In addition to its therapeutic pipeline, Shuttle Pharmaceuticals Holdings, Inc. is involved in cancer-focused diagnostics and drug-development technologies that connect oncology research with precision medicine workflows. Headquartered in Gaithersburg, Maryland, the company operates as a small, research-driven healthcare business positioned within the broader pharmaceutical and biotechnology market.
Website401 Professional Drive
Gaithersburg, MD, 20879
United States
Summary of Aug 10's posts. Generated by AI.
Summary of Jul 31's posts. Generated by AI.
Summary of Aug 10's posts. Generated by AI.
Investors talking about SHPH also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.